McDermott + Bull has successfully placed Julianna Uresch as Senior Director of Upstream Marketing at Vista.ai. In this role, Julianna will lead product strategy and market development for Vista.ai’s AI-powered MRI platform, Vista Cardiac, and future applications...
McDermott + Bull has successfully placed Glebb Popov, CPA as Vice President of Finance + Accounting at RxSight. Glebb will oversee the company’s financial strategy, accounting operations, and fiscal health, ensuring efficient financial management as the...
McDermott + Bull has successfully placed Michael Selberis as Chief Technology Officer at ClinNEXUS. Michael will lead the development and execution of ClinNEXUS’s technology strategy, overseeing all aspects of technological direction to ensure alignment with the...
IRVINE, CA (January 7, 2025) – McDermott + Bull, the go-to executive search partner to empower change, is pleased to announce the promotion of Shelby Varon to Managing Director within the firm’s Life Sciences + HealthTech Practice, based in Irvine, California. Shelby...
After a subdued start to the year, PE healthcare services investing in Q3 2024 showed early signs of a rebound. Despite a modest dip in deal volume from Q2, with 148 deals announced or closed, investor confidence is slowly returning. Much of the activity focused on...
What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
